EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, Chief Executive Officer of NovaBay Pharmaceuticals, Inc. (AMEX: NBY, www.novabaypharma.com), a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial, fungal, and viral infections, has been featured in the latest edition of Cambridge Healthtech Institute’s Insight Pharma Report.
